BOGDAN WLODARCZYK to Drug Evaluation, Preclinical
This is a "connection" page, showing publications BOGDAN WLODARCZYK has written about Drug Evaluation, Preclinical.
Connection Strength
0.104
-
Preclinical evaluation of 2,2,3,3-tetramethylcyclopropanecarbonyl-urea, a novel, second generation to valproic acid, antiepileptic drug. Neuropharmacology. 2006 Sep; 51(4):933-46.
Score: 0.060
-
Design and Comparative Evaluation of the Anticonvulsant Profile, Carbonic-Anhydrate Inhibition and Teratogenicity of Novel Carbamate Derivatives of Branched Aliphatic Carboxylic Acids with 4-Aminobenzensulfonamide. Neurochem Res. 2017 Jul; 42(7):1972-1982.
Score: 0.031
-
Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in mice. Br J Pharmacol. 2003 Jun; 139(4):755-64.
Score: 0.012